Curis | CRIS - Selling And Administration Expenses


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Curis

Curis reported $4.76M in Selling and Administration Expenses for its fiscal quarter ending in March of 2023.


Selling And Administration Expenses Change
Alaunos Therapeutics Inc ZIOP:US USD 3.17M 243K
Amgen AMGN:US USD 1.26B 210M
AstraZeneca AZN:LN USD 3.2B 331M
Bayer BAYN:GR EUR 4.05B 374M
Bristol-Myers Squibb BMY:US USD 1.76B 504M
Chimerix CMRX:US USD 5.68M 332K
Curis CRIS:US USD 4.76M 430K
Eli Lilly LLY:US USD 1.75B 106M
Exelixis EXEL:US USD 131.4M 12.15M
Gilead Sciences GILD:US USD 1.32B 702M
GlaxoSmithKline GSK:LN GBP 2.06B 370M
Incyte Corp INCY:US USD 315.61M 42.79M
Merck & Co MRK:US USD 2.46B 209M
Mirati Therapeutics MRTX:US USD 73.49M 2.67M
Novartis NOVN:VX USD 3.4B 298M
Pfizer PFE:US USD 3.49B 1.39B
Roche Holding ROG:VX 6.48B 834M
Spectrum Pharmaceuticals SPPI:US USD 14M 2.7M
Takeda 4502:JP JPY 254.8B 7.5B
TG Therapeutics TGTX:US USD 28.07M 5.56M
Verastem VSTM:US USD 7.33M 1.22M
Xoma XOMA:US USD 6.2M 1.38M